Skip to main navigation Skip to search Skip to main content

Genomic epidemiology of artemisinin resistant malaria

  • MalariaGEN Plasmodium falciparum Community Project
  • Wellcome Sanger Institute
  • University of Oxford
  • Mahidol University
  • Nuffield Department of Medicine
  • Medical Research Council Unit at the LSTHM
  • US Department of Health and Human Services
  • University for Development Studies Ghana
  • Institut Pasteur de Madagascar
  • University of Buea
  • Charles Darwin University
  • National Institute for Medical Research Tanzania
  • University of Antwerp
  • Walter and Eliza Hall Institute of Medical Research
  • University of Melbourne
  • Kenya Medical Research Institute
  • University of Tübingen
  • London School of Hygiene & Tropical Medicine
  • New York University
  • Liverpool School of Tropical Medicine
  • University of Bamako
  • Purdue University
  • Centro Internacional de Entrenamiento e Investigaciones Médicas - CIDEIM
  • Med Biotech Laboratories Uganda
  • Malaria Research Group and Dev Care Foundation
  • National Centre for Parasitology, Entomology and Malaria Control
  • Armed Forces Research Institute of Medical Sciences (USAMC-AFRIMS)
  • Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU)
  • University of Health Sciences
  • Divine Word University
  • University of Ilorin
  • Pennsylvania State University
  • Ministry of Health
  • Shoklo Malaria Research Unit
  • Eijkman Institute for Molecular Biology
  • King Fahd University of Petroleum and Minerals
  • Malawi-Liverpool-Wellcome Trust Clinical Research Programme
  • Université de Kinshasa
  • Health Sciences Research Institute (IRSS)
  • University of Maryland School of Medicine
  • World Health Organization
  • Universidad Nacional de la Amazonia Peruana
  • University of Dodoma
  • Papua New Guinea Institute of Medical Research

Research output: Contribution to journalArticlepeer-review

217 Citations (Scopus)

Abstract

The current epidemic of artemisinin resistant Plasmodium falciparum in Southeast Asia is the result of a soft selective sweep involving at least 20 independent kelch13 mutations. In a large global survey, we find that kelch13 mutations which cause resistance in Southeast Asia are present at low frequency in Africa. We show that African kelch13 mutations have originated locally, and that kelch13 shows a normal variation pattern relative to other genes in Africa, whereas in Southeast Asia there is a great excess of non-synonymous mutations, many of which cause radical amino-acid changes. Thus, kelch13 is not currently undergoing strong selection in Africa, despite a deep reservoir of variations that could potentially allow resistance to emerge rapidly. The practical implications are that public health surveillance for artemisinin resistance should not rely on kelch13 data alone, and interventions to prevent resistance must account for local evolutionary conditions, shown by genomic epidemiology to differ greatly between geographical regions.

Original languageEnglish
Article numbere08714
JournaleLife
Volume5
Issue numberMARCH2016
DOIs
Publication statusPublished - 4 Mar 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Genomic epidemiology of artemisinin resistant malaria'. Together they form a unique fingerprint.

Cite this